| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immix Biopharma, Inc. (IMMX) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. IMMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.14M | $11.98M | - | |
| CFO | 291.4K | $3.06M | - | |
| Dir | 39.6K | $415.9K | - | |
| 10% | 33.0K | $346.2K | - | |
| Dir | 33.0K | $346.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Morris Gabriel S65 | CFO | Buy | 2,500 | $2.12 | $5,298.00 | +0.9% | +3.4% | +16.7% | |
| Jun 7, 2024 | Rachman Ilya M64 | CEO And Chairman | Buy | 2,600 | $2.13 | $5,538.00 | +0.2% | +3.4% | +16.7% | |
| Jun 4, 2024 | Rachman Ilya M64 | CEO And Chairman | Buy | 3,300 | $1.81 | $5,970.03 | +0.3% | +12.7% | +13.8% | |
| Jun 4, 2024 | Morris Gabriel S65 | CFO | Buy | 3,300 | $1.81 | $5,972.67 | +1.2% | +12.7% | +13.8% | |
| May 14, 2024 | Morris Gabriel S65 | CFO | Buy | 4,500 | $2.23 | $10,041.75 | +5.5% | -15.9% | -10.0% | |
| May 14, 2024 | Rachman Ilya M64 | CEO And Chairman | Buy | 4,300 | $2.25 | $9,659.95 | +0.5% | -15.9% | -10.0% | |
| Dec 11, 2023 | Hsu Jason50 | Director | Buy | 56,000 | $4.77 | $266,919.00 | +3.6% | -33.3% | -52.6% | |
| Sep 15, 2023 | Hsu Jason50 | Director | Buy | 72,000 | $2.78 | $200,312.40 | +2.5% | +112.7% | -30.3% | |
| Sep 14, 2023 | Ng Carey | Director | Buy | 10,000 | $2.58 | $25,760.00 | New | +64.2% | -26.8% | |
| Sep 12, 2023 | Adams Helen C. | Director | Buy | 13,000 | $2.96 | $38,491.70 | New | +66.2% | -33.1% |